In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens

Peter J. Petersen, Patricia A. Bradford, William J. Weiss, Timothy M. Murphy, P. E. Sum, Steven J. Projan

Research output: Contribution to journalArticlepeer-review

146 Scopus citations

Fingerprint Dive into the research topics of 'In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens'. Together they form a unique fingerprint.

Medicine & Life Sciences